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Allergic fetal priming leads to developmental, behavioral and
neurobiological changes in mice
JJ Schwartzer1, M Careaga2, C Chang2, CE Onore2 and P Ashwood2
The state of the mother’s immune system during pregnancy has an important role in fetal development and disruptions in the
balance of this system are associated with a range of neurologic, neuropsychiatric and neurodevelopmental disorders.
Epidemiological and clinical reports reveal various clues that suggest a possible association between developmental
neuropsychiatric disorders and family history of immune system dysfunction. Over the past three decades, analogous increases
have been reported in both the incidence of neurodevelopmental disorders and immune-related disorders, particularly allergy and
asthma, raising the question of whether allergic asthma and characteristics of various neurodevelopmental disorders share
common causal links. We used a mouse model of maternal allergic asthma to test this novel hypothesis that early fetal priming with
an allergenic exposure during gestation produces behavioral deficits in offspring. Mothers were primed with an exposure to
ovalbumin (OVA) before pregnancy, then exposed to either aerosolized OVA or vehicle during gestation. Both male and female
mice born to mothers exposed to aerosolized OVA during gestation exhibited altered developmental trajectories in weight and
length, decreased sociability and increased marble-burying behavior. Moreover, offspring of OVA-exposed mothers were observed
to have increased serotonin transporter protein levels in the cortex. These data demonstrate that behavioral and neurobiological
effects can be elicited following early fetal priming with maternal allergic asthma and provide support that maternal allergic asthma
may, in some cases, be a contributing factor to neurodevelopmental disorders.
Translational Psychiatry (2015) 5, e543; doi:10.1038/tp.2015.40; published online 7 April 2015
INTRODUCTION
Developmental neuropsychiatric disorders are heterogeneous in
their presentation and often share common behavioral character-
istics across diagnoses. For example, social behavior deficits,
including difficulties relating to others, impaired mood regulation
and cognitive impairments are apparent in autism spectrum
disorders (ASD), schizophrenia, attention deficit/hyperactivity
disorder (ADHD) and bipolar disorder. These shared characteristics
represent plausible endophenotypes that may result from a
common etiological mechanism. Although bipolar disorder and
schizophrenia emerge later in life, these disorders along with
other neurodevelopmental disorders, such as ASD and ADHD, are
thought to have developmental origins early in the prenatal
period.1–3 Although genetic factors are likely contributors to these
disorders, heritability estimates indicate strong environmental
contributions.4 Of particular interest is the link between fetal
gestation and the activation of the maternal immune system
during critical periods of development. Epidemiological reports
suggest a strong association between periods of maternal
immune activation and an increased risk of having a child with
a neurodevelopmental disorder.5–7 This association is concerning
given the parallel increases reported in the incidence of immune-
related disorders, in particular asthma and allergies, over the past
decade.8–11
Much of the clinical and preclinical research has focused on the
consequences of maternal pathogen exposure, such as bacteria
and viruses, on fetal development. Pro-inflammatory factors
released in response to viral or bacterial infections have been
associated with schizophrenia, ASD, ADHD and bipolar
disorder,7,12–14 highlighting the immune response, not the specific
pathogenic agent, as a contributing factor to the etiology of these
diseases.15 However, unique immune cascades may be evoked in
response to other immunogenic agents that are not of viral or
bacterial origin. For example, allergies and asthma represent an
alternative inflammatory response mediated by a T-helper type 2
(TH2) polarization resulting in humoral responses. Although both
viral/bacterial and allergen-induced stimuli result in activation of
the maternal immune system, different cytokine profiles and/or
signaling cascades may contribute to unique consequences on
fetal brain development. To date, little is known about the
developmental consequences of maternal TH2-mediated
responses, such as the effects of allergy/asthma induction, on
fetal development. This is particularly important given the rises in
allergies observed16 and the recent epidemiological links found
between maternal allergies and risk of neurodevelopmental
disorders.17,18 These associations warrant a need to examine the
neuroimmunological effects of maternal allergies and asthma on
offspring development and behavior.
To date, preclinical investigations of maternal immune activa-
tion have relied exclusively on the use of viral and bacterial
agents, most notably polyinosinic-polycytidylic acid [poly(I:C)] and
lipopolysaccharide, to identify behavioral consequences of sys-
temic prenatal infection.15,19 Many of these reports have observed
changes in various behaviors analogous to the common
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behavioral characteristics present across neurodevelopmental
disorders including altered social behavior,20,21 motor activity,22
anxiety23 and learning and memory impairments.22,23 Although
these findings demonstrate a link between maternal immune
activation and neurodevelopmental deficits, the translational
validity of pathogen-induced fetal priming is limited as rates of
pathogen infection in developed countries have markedly
declined over the past century.24 Conversely, incidence of
neurodevelopmental disorders, such as ASD, are increasing at an
alarming rate.25 This inconsistency suggests that maternal viral/
bacterial infection is unlikely the cause of all cases of neurode-
velopmental disorders and raises the question whether other
immunogenic agents, particularly those stimuli that are currently
on the rise, such as allergy and asthma, equally impact
neurodevelopmental and neuropsychiatric disease prevalence.
The immune and nervous system are intimately connected
throughout development as perturbations in one system impart
developmental changes in the other.26 Among the numerous
signaling pathways important for brain development, the
serotonergic system emerges early in brain development, even
before the establishment of conventional synapses, and has a vital
role in neuronal proliferation, migration and synapse
formation.27,28 Moreover, accumulating evidence suggests that
modification of the serotonergic system contributes to dysfunc-
tional brain development associated with numerous neurodevel-
opment disorders. The serotonin transporter (SERT) has a central
role in the regulation of serotonin signaling and pharmacological
targets at this site, including the widely used selective serotonin
reuptake inhibitors, are among the most popular treatments for
several neurodevelopmental and neuropsychiatric disorders.
Importantly in mice, SERT is present as early as embryonic day
8, a period when placental serotonin is believed to impart
substantial influence on forebrain development29,30 and expres-
sion of serotonergic proteins like SERT are regulated in response
to immune system factors. This intimate connection between
immune signaling cascades and brain development place the
serotonin system, particularly SERT, at the apex of immune-related
mental health and warrant investigation of how maternal
exposure to allergy/asthma during pregnancy alters brain devel-
opment, starting with changes in SERT forebrain expression.
We describe the first set of studies that tested the hypothesis
that maternal allergy/asthma (MAA) imparts neurobehavioral
alterations in brain and behavior of offspring reminiscent of the
common endophenotypes observed in neurodevelopmental
disorders. To test this, pregnant dams were induced with allergic
airway inflammation and their offspring were measured for
developmental and behavioral alterations to identify changes in
sociability (social approach and dominance), repetitive and
perseverative behaviors (grooming and marble burying), and
hyper/hypoactivity (locomotor activity). In addition, offspring were
assessed for general anxiety (elevated plus maze) and basic
learning and memory behavior (novel object recognition) to
identify whether differences in arousal states or cognitive ability
contributed to behavioral changes. In addition, to begin to
address potential mechanisms, brains of offspring born to MAA
dams were examined for evidence of altered SERT expression
following behavioral analysis.
MATERIALS AND METHODS
Animals
Male and female C57Bl/6J mice generated from breeding pairs purchased
from Jackson Laboratory (Sacramento, CA, USA) were bred and maintained
by the Center for Laboratory Animal Research, at the University of
California, Davis, and maintained at ambient room temperature on a 12 h
light/dark cycle (lights on at 0600 h). In addition, 129/SvImJ mice (Jackson
Laboratory) were used as stimulus mice for the social approach task. Mice
were group housed in standard plastic cages with same-sex litter mates,
unless otherwise noted. Cages were maintained in a temperature- (20 °C)
and humidity (55%)-controlled vivarium with food and water provided ad
libitum. All behavioral tasks were performed during the first 4 h of the light
cycle, and all procedures were performed with approval by the University
of California, Davis Institutional Animal Care and Use Committee and in
accordance with the guidelines provided by the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Maternal allergy/asthma induction
Sexually naive female C57Bl/6J mice were sensitized with a single
intraperitoneal injection of 10 μg ovalbumin (OVA, Sigma, St Louis, MO,
USA) in 1mg (Al)OH3 (InvivoGen, San Diego, CA, USA) dissolved in 200 μl
phosphate-buffered saline (PBS) on postnatal day (P)42 and again 1 week
later at P49. One week following the second sensitization treatment,
female mice were mated overnight and checked daily for the presence of a
seminal plug, noted as gestational day 0.5. Pregnant mice were randomly
assigned to either the allergic asthma or control group and exposed to
either an aerosolized solution of 1% (wt/vl) OVA in PBS (that is, the MAA
group) or PBS control for three 45-minute induction sessions throughout
gestation. Specifically, these induction sessions occurred at gestational
days 9.5, 12.5 and 17.5, to correspond with early, middle and late gestation,
as previously described.21,31–33 Following the final induction, mice were
returned to their home cages, single housed and left undisturbed until the
birth of their litters. Pups remained with their mother until weaning on
P21, at which time the offspring were group housed with same-sex
littermates. A total of 23 dams (11 PBS and 12 MAA) were used to generate
82 offsprings (39 PBS, 43 MAA).
Experimental design
Experimental offspring were separated into two cohorts to reduce the total
number of behavioral tasks imparted on any one animal. For cohort 1,
juvenile offspring were weighed and body length measured from P4 until
P16 to identify difference in developmental trajectories. After weaning,
these mice were tested for social approach behavior at 8 weeks of age
followed by grooming and marble-burying tasks at 9 weeks of age. At
10 weeks old, mice in cohort 1 were measured for locomotor activity in the
open-field arena followed by memory performance in the novel object
recognition task. In cohort 2, 8-week-old mice were first tested for anxiety-
like behavior in the elevated plus maze task to mitigate the potential
anxiogenic effects of subsequent behavioral testing. One week following
the elevated plus maze task, these mice were tested for social behavior
deficits in the social approach task. Finally, at 10 weeks of age, mice in
cohort 2 were tested for grooming and marble-burying behavior.
Social approach
Changes in social approach behavior were measured between offspring of
MAA and PBS-exposed dams using the three-chambered social approach
task as previously described.33–35 Mice were placed in the center chamber
and allowed to habituate for 10min followed by an additional 10 min of
free exploration of all three chambers to confirm the absence of a side
preference. Then, experimental animals were returned to the center
chamber while a sex-matched novel 129/SvImJ mouse was placed under
an inverted wire cup in one side chamber, and an identical empty wire cup
was placed on the other side. Mice were then given an additional 10-min
period to explore both chambers and the time spent in each chamber was
measured. The chamber containing the novel mouse was counter
balanced to control for any bias in chamber preference. A sociability
score was calculated as the time spent in the novel mouse chamber minus
time spent in the novel-object chamber.
Social dominance tube test
Social anxiety was evaluated on the basis of differences in social
dominance using methods adapted from Spencer et al.36 One offspring
of a MAA dam and one offspring of a PBS-exposed dam were placed head
first at opposite ends of a 30-cm long acrylic tube (2.5-cm diameter) and
released simultaneously. After meeting in the center, the less dominant
mouse backed out leaving the ‘winning’ mouse remaining in the tube.
Each mouse was tested four times, each time with a novel same-sex
opponent from the opposing treatment group, and the entry side was
counter balanced across trials. For each trial, the winning mouse was
granted a score of 1 and the submissive mouse earned 0. Matches lasting
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for more than 2min with neither animal backing out ended in a draw, and
each mouse received a score of 0.5.
Marble burying
One week following the social approach task, mice were habituated for
10min to a clean Plexiglas cage (37 × 14× 12.5 cm) filled with a 4-cm thick
layer of clean corncob bedding. Following habituation, animals were
returned to their home cage and 15 glass marbles were laid out in five
rows of three marbles placed equidistance apart. Mice were then returned
to their cages and allowed to explore under dim illumination for 10min. At
the end of the 10-min period, animals were gently removed from the
testing cages and the number of marbles buried was recorded. Only
marbles covered by 75% or more bedding were counted as buried, as
previously described.21,33
Grooming
Two days after marble burying, animals were placed in an empty clean
Plexiglas cage and left undisturbed to habituate for 10min. Following
habituation, mice were video recorded for 10min and later scored for self-
grooming behavior by two individuals blind to treatment conditions.
Grooming was defined as time spent licking paws, washing the nose and
face, or scratching fur with any foot.
Locomotor activity
Experimental animals were individually placed in an empty Plexiglas arena
(30 cm×30 cm×38 cm) and allowed to freely explore the environment for
10min. Horizontal locomotor activity was assessed using Ethovision XT 9
(Noldus Information Technology, Leesburg, VA, USA) video tracking
software to measure total distance traveled and average velocity during
the 10-min exploration task.
Novel-object recognition
Memory performance was assessed in the open-field arena beginning with
a 10-minute habituation period. The following day, mice were returned to
the cleaned arena and allowed to freely explore two identical objects for a
10-minute familiarization phase. Twenty-four hours later, one of the
familiar objects was replaced with a novel object and experimental mice
were returned to the arena and video recorded for a 5-min testing session.
Object investigation, as defined by the time spent sniffing either the
familiar or novel object, was measured by two trained observers. Novel-
object recognition was calculated by measuring the time spent sniffing the
novel object divided by the total time sniffing either object. Novel-object
sniff times significantly greater than 50% indicate object recognition. All
objects and arenas were cleaned between each testing session with 70%
ethanol to remove olfactory cues.
Elevated plus maze
The apparatus was constructed of dark gray Plexiglas and consisted of two
open arms (30 cm×5 cm×0.25 cm) and two perpendicular closed arms
(30 cm×5 cm×15 cm) extending from a central platform. The entire
apparatus was elevated ~ 1m above the floor. At the start of testing, mice
were placed on the center platform and allowed to freely explore the maze
for 5 min. Behavioral responses were video recorded and later measured
for the number of entries into each arm, as defined by all four paws in the
arm, as well as the time spent in the open and closed portions of the maze.
The percent of time spent exploring the open arms was calculated by the
time in the open arm divided by the total time spent in either the open or
closed arms. Reductions in open arm exploration were interpreted as
increased anxiety.
Immunoblot
One week following behavioral testing, one male and one female mouse
from each litter were deeply anesthetized with isoflurane (4% inhalation)
and brains removed for immunoblot analysis. Dissected cortex was
homogenized in ice-cold lysis buffer containing 20 mM Tris-HCl (pH 7.5),
150mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium
deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate,
1 mM Na3VO4 and 1 μgml
− 1 leupeptin (Cell Signaling, Danvers, MA, USA).
Lysates were then sonicated for 30 s and vortexed for 30 s before being
centrifuged at 20 000 g for 10 min. Supernatants were collected and total
protein was quantified by Bradford assay (Thermo-Fisher, Rockford, IL,
USA). Twenty micrograms total protein were loaded onto a 4–20%
Criterion XT precast gel (Bio-Rad, Hercules, CA, USA) per sample and
electrophoresed at 100 V. The separated proteins were then transferred to
a nitrocellulose membrane (Bio-Rad) at 100 V. After transfer, the membrane
was blocked in 5% milk in Tris-buffered saline (TBS) for 1 h at room
temperature. The membrane was then probed overnight at 4 °C in TBS
with 0.05% Tween-20 (TBST; Sigma) using a dilution of 1:250 goat anti-SERT
(Santa Cruz Biotechnology) and 1:5000 rabbit anti-β-Actin (Cell Signaling)
antibodies. This was followed by incubation with donkey anti-goat
conjugated to horseradish peroxidase (JacksonImmuno, West Grove, PA,
USA) and donkey anti-rabbit conjugated to horseradish peroxidase both at
1:10 000 in TBST for 1 h at room temperature. Bands were then visualized
using SuperSignal West Dura Chemiluminescent Substrate (Thermo-Fisher)
using an Alpha Innotech FluorChem 8800 Image Detection System
(ProteinSimple, Santa Clara, CA, USA). Bands were quantified by
densitometry using Alphaview version 3.2.2 (ProteinSimple).
Statistics
Data were analyzed using SPSS Version 20 (Chicago, IL, USA). Initial
parturition rates were analyzed across dams using a chi-square analysis
(treatment × outcome). For repeated measures data of weight and length
across development, linear mixed effects models were used with each pup
as the analysis unit nested within litters. This approach allows for multiple
mice to be tested within a litter while controlling for litter effects.37,38
Similarly for the social approach task, chamber, treatment, sex and relevant
interactions were treated as fixed effects, and dam was treated as a
random effect. For all univariate analyses, linear mixed model was used
with each experimental offspring as the analysis unit, treatment, sex and
treatment by sex interactions as fixed effects, and dam as a random effect
to control for litter effects. Immunoblot data were analyzed using a two-
way factorial analysis of variance with treatment and sex as independent
variables. SERT levels were correlated with behavioral measures using
Spearman’s rho when applicable. All statistical tests were two-tailed with
alpha set at 0.05.
RESULTS
Parturition, growth and development
Repeated challenge with aerosolized OVA produced a robust
inflammatory response, observed in maternal sera and bronch-
oalveolar lavage fluid (BALF), with the characteristic allergy/
asthma cytokine profile previously described in mice39–42 (see
Supplementary Materials). To determine whether this OVA-
induced immune activation during pregnancy resulted in altered
parturition rates, a chi-square analysis was performed between
MAA and PBS-exposed dams for the number of full-term, aborted
and cannibalized litters. Out of 27 initial litters, only two litters
were cannibalized following parturition (one PBS and one MAA)
and two additional pregnancies did not come to term (two PBS,
zero MAA). The majority of pregnancies (11 PBS and 12 MAA) were
full term with no significant differences between treatment
groups, χ2(2,n= 27) = 2.074, P= 0.355.
Offspring born to mothers with repeated exposure to allergic
asthma treatment (that is, MAA group) showed altered weight and
length developmental trajectories throughout juvenile develop-
ment (Figure 1). Offspring of both treatment groups showed
significant increases in body length as a main effect of
developmental day, F(6,74) = 325.434, Po0.001; however, offspring
of MAA-exposed dams were significantly longer throughout all
developmental time points, F(1,213) = 79.054, Po0.001. Moreover,
repeated measures analysis of variance revealed a significant
day × treatment interaction for pup length, F(6,74) = 2.286, P= 0.044
(Figure 1a). Similarly, although offspring of both MAA and PBS-
exposed dams exhibited significant weight gain throughout the
initial three weeks of life, F(6,64) = 216.012, P= 0.001, offspring of
MAA-exposed dams weighed significantly more than PBS controls
as indicated by a main effect for treatment, F(1,198) = 45.992,
P= 0.0001 (Figure 1b). This weight gain was independent of
developmental day, F(6,64) = 1.165, P= 0.336. Interestingly, by
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10 weeks of age, these differences in body mass were no longer
present between treatment groups, F(1,27) = 0.110, P= 0.742
(Figure 1c).
Social behaviors
During the initial habituation phase of the social approach task,
there was no baseline preference for either empty chamber
between treatment groups: main effect chamber, F(1,162) = 0.002,
P= 0.969; main effect treatment, F(1,162) = 0.036, P= 0.850; chamber
by treatment interaction, F(1,162) = 0.381, P= 0.538, indicating no
inherent bias at the start of the behavioral task. During the
subsequent social approach phase, there was a significant main
effect for chamber preference, with mice spending significantly
more time in the mouse chamber compared with the object
chamber F(1,162) = 65.979, P= 0.0001 (Figure 2a). This preference for
the social chamber was apparent in both treatment groups as
indicated by a null effect for treatment, F(1,162) = 0.272, P= 0.603
and treatment by chamber interaction F(1,162) = 0.606, P= 0.438.
Specifically, both MAA and PBS offspring spent significantly more
time in the chamber with the mouse compared with the chamber
with the novel object. However, analysis of the strength of the
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social preference between treatment groups revealed a significant
decrease in sociability in MAA offspring compared with PBS
control offspring F(1,79) = 4.225, P= 0.043. Offspring of MAA-
exposed dams had a 33% decrease in the sociability score,
indicating a deficit in social behavior compared with offspring of
PBS-exposed dams (Figure 2b). This difference in sociability was
independent of sex, main effect: F(1,79) = 0.421, P= 0.518; sex by
treatment interaction: F(1,79) = 0.836, P= 0.363. Deficits in
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Novel Object Recognition
Pe
re
ce
nt
 n
ov
el
 o
bje
ct 
sni
ff 
(M
ean
±S
EM
)
0
25
50
75
100
PBS
MAA
Distance Traveled 
D
ist
an
ce
 in
 c
m
 (M
ea
n±
SE
M
)
0
1000
2000
3000
4000
5000
PBS
MAA
Average Velocity
V
el
ci
ty
 in
 c
m
/se
co
nd
 (M
ea
n±
SE
M
)
0
2
4
6
8 PBS
MAA
Percent of Time in Open Arm
Pe
rc
en
t o
f T
im
e 
(M
ea
n±
SE
M
)
0
20
40
60
80
100
PBS
MAA
Entries into Open Arm
N
um
be
r o
f E
nt
rie
s (
M
ea
n±
SE
M
)
0
4
8
12
16
20
PBS
MAA
Total Entries
N
um
be
r o
f E
nt
rie
s (
M
ea
n±
SE
M
)
0
10
20
30
40 PBS
MAA
Figure 4. Measures of locomotor activity, memory formation and anxiety. No differences were observed in (a) the total distance traveled or (b)
average velocity between treatment groups during the open-field observations. (c) Mice from both MAA- and PBS-exposed dams showed
normal object recognition as measured by a preference (that is, 450% sniffing) for a novel versus familiar object. (d) There were no
differences observed in the percent of time spent in the open arms of the elevated plus maze arena between treatment groups. (e) Similarly,
no differences were observed in the total number of entries into the open arm between offspring of PBS-treated and MAA dams. (f) These
similarities parallel similarities in the total number of entries into all arms of the maze, an internal control for locomotor activity. MAA, maternal
allergic asthma; PBS, phosphate-buffered saline.
Maternal allergy/asthma and offspring development
JJ Schwartzer et al
5
Translational Psychiatry (2015), 1 – 10
sociability between MAA and PBS groups were brought on by a
significant increase in the time spent with the novel object by
offspring of MAA dams, F(1,79) = 4.079, P= 0.047, as well as a trend
towards a decrease in the time spent with the novel mouse, F(1,79)
= 3.590, P= 0.062 (Figure 2c).
No significant differences were observed in social dominance
between PBS and MAA groups (Figure 2d). Analysis of variance
revealed no difference in the percentage of matches won
between treatment groups F(1,26) = 0.709, P= 0.407. In fact, off-
spring from both MAA-exposed dams and control PBS-exposed
dams won ~ 50% of all tube test bouts. The average number of
wins was independent of sex as revealed by a null effect for sex, F
(1,26) = 0.061, P= 0.806, as well as no sex by treatment interaction, F
(1,26) = 0.061, P= 0.806.
Repetitive and perseverative behaviors
In mice, marble-burying is used as an index of perseverative
digging behavior analogous to the restricted, repetitive patterns
of behavior observed in neurodevelopmental disorders.43 Off-
spring of MAA-exposed dams buried significantly more marbles
compared with offspring of PBS control dams (Figure 3a), as
indicated by a main effect for treatment F(1,78) = 4.854, P= 0.031.
Interestingly, a significant main effect for sex was observed, F(1,78)
= 6.340, P= 0.014, with male mice burying a greater percentage of
marbles compared with females. This sex difference was
independent of treatment as noted by a null sex by treatment
interaction: F(1,78) = 2.074, P= 0.154.
The total time spent grooming during a 10-min period was
significantly reduced in offspring of MAA-exposed dams com-
pared with typically developing mice born to control dams
(Figure 3b). When controlling for variations across litters, linear
mixed effects model revealed a significant main effect of
treatment for grooming times F(1,81) = 4.21, P= 0.043. On average,
there was a 25% reduction in grooming time for offspring of
MAA-exposed dams (mean= 44.36, s.d. = 34.30) compared with
offspring of PBS-exposed dams (mean= 60.41, s.d. = 36.49). Inter-
estingly, there was a significant main effect for sex, F(1,52) = 5.380,
P= 0.024, with males spending significantly more time grooming
compared with females. This sex-specific difference was apparent
regardless of treatment group as observed by a null sex by
treatment interaction, F(1,52) = 0.038, P= 0.846.
Hypo/hyperactivity
To determine whether phenotypic differences between offspring
of MAA- and PBS-exposed dams were due to hyper/hypoactivity,
mice were placed in an open arena and measured for locomotor
behavior. Between treatment groups, no differences were
observed in either the total distance traveled, F(1,27) = 0.001,
P= 0.994 (Figure 4a), or average velocity, F(1,27) = 0.165, P= 0.688,
demonstrating similar locomotor activity between offspring of
MAA- and PBS-exposed dams (Figure 4b). Moreover, there were
no main effects for sex (distance traveled, F(1,27) = 0.538, P= 0.496;
average velocity, F(1,27) = 0.317, P= 0.578) and no sex by treatment
interactions (distance traveled, F(1,27) = 0.037, P= 0.849; average
velocity, F(1,27) = 0.004, P= 0.849).
Learning and memory
To determine whether reductions in social behavior are due to
deficits in cognition, offspring from MAA- and PBS-exposed dams
were measured for alterations in memory performance using the
novel-object recognition task. One day following the memory
acquisition phase, offspring of MAA- and PBS-exposed dams spent
significantly more time exploring the novel object, as indicated by
a novel-object exploration time 450% (one-sample t-test): PBS, t
(15) = 3.569, P= 0.003; MAA, t(15) = 3.967, P= 0.001. There were no
significant differences in the percentage of time spent exploring
the novel object between sex, F(1,27) = 1.608, P= 0.216 or treatment
groups, F(1,27) = 0.003, P= 0.954, suggesting equal memory forma-
tion between offspring of PBS and MAA dams (Figure 4c).
Anxiety-like behavior
There was no significant difference in the percentage of time
spent in the open arms of the elevated plus maze between
treatment groups, F(1,49) = 1.789, P= 0.187, as well as no difference
between sex F(1,49) = 0.018, P= 0.892 or sex by treatment interac-
tions F(1,49) = 0.182, P= 0.671, indicating an absence of a high
anxiety-like phenotype in offspring of MAA-exposed dams
(Figure 4d). Moreover, offspring of both MAA and PBS-exposed
dams made equal number of entries into the open arms of the
maze F(1,49) = 0.796, P= 0.377 (Figure 4e) as well as similar number
of total entries into any arm F(1,49) = 0.589, P= 0.447 (Figure 4f).
Serotonin transporter expression
The analysis of serotonin transporter protein levels in the cortex of
MAA and PBS offspring revealed a significant main effect for
treatment, F(1,12) = 9.67, P= 0.011. Mice born to dams exposed to
MAA had a 33% increase in the expression of SERT compared with
control offspring of PBS-exposed dams (Figure 5). These
differences did not differ between males and females as indicated
by a null effect for sex, F(1,12) = 0.678, P= 0.429, as well as no sex by
treatment interactions, F(1,12) = 0.066, P= 0.803. Increases in SERT
expression in the cortex positively correlated with marble-burying
behavior, rs(14) = 0.602, P= 0.023, with mice expressing the
highest SERT levels burying the greatest number of marbles.
These correlations between SERT expression and behavior were
not evident in any other behavior measured.
DISCUSSION
Activation of the maternal immune system with an allergy/asthma
insult significantly perturbed developmental growth and species-
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Figure 5. Immunoblot analysis of serotonin transporter (SERT)
protein expression in the cortex. Mice born from mothers sensitized
to OVA before pregnancy and repeatedly challenged with aero-
solized OVA during pregnancy had significantly greater expression
of SERT in the cortex compared with typically developing mice born
to PBS control dams. *Po0.05. MAA, maternal allergic asthma; OVA,
ovalbumin; PBS, phosphate-buffered saline.
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typical behaviors in offspring. Our maternal allergy/asthma model
produced an offspring phenotype characteristic of impaired social
approach. Animal models of maternal immune activation using
the viral mimic polyI:C report similar reductions, but not
elimination, of sociability.21,33 Offspring of MAA dams also
exhibited increased marble-burying behavior, a perseverative
behavior analogous to repetitive behaviors observed in neuro-
psychiatric disorders including obsessive compulsive disorder and
ASD.43 In addition, we observed disturbances in the serotonin
pathway with increased SERT evident in offspring of MAA-exposed
dams. Excessive marble burying positively correlated with SERT
levels and may reflect hyperactivity or motor stereotypies that are
reminiscent in ADHD and ASD. Surprisingly, offspring of MAA-
exposed dams exhibited decreased self-grooming, a behavioral
trait often used to model the repetitive self-directed behaviors in
individuals with ASD. Given that others have also noted
incongruence between grooming and marble-burying behavior in
mice,44,45 the discrepancies in these behavioral responses
suggests the presence of diverse underlying mechanisms for
different types of repetitive behaviors and underscore the
importance of identifying endophenotypes that may be funda-
mental to behaviors observed across different neurodevelop-
mental disorders.
The sociability deficits observed in MAA offspring model the
social behavior impairments characteristic of many neurodevelop-
mental disorders. These impairments are hypothesized to be
secondary expressions of more fundamental deficits in brain
processes related to attention, motivation and neurospecialization
for social cognition.46,47 Although initial measures of basic
learning/memory processes using the novel-object recognition
task appear to be intact, more specialized cognitive functions are
warranted to tease apart endophenotypes associated with
maternal allergy and asthma responses. Indeed, novel-object
recognition provides a rapid measure of memory formation and
learning but is limited in its specificity for assessing attention.48
More precise attention tasks requiring sustained attention such as
the five-choice serial reaction time test may provide a deeper
understanding of the neural alterations imparted by MAA.
Similarly, other fundamental brain processes including changes
in motivation and social recognition may be contributing to the
social behavior deficits observed. For example, in a strain-specific
mouse model of ASD, the BTBR mouse exhibits complex cognitive
deficits in probabilistic learning, attention, social motivation and
transitive inferences that likely underlie the social behavior deficits
characteristic of this mouse model.49 Thus, further exploration of
how MAA alters more fundamental processes contributing to
social behaviors is needed to identify the distinct mechanisms
contributing to reduced social approach.
Aside from the behavioral phenotype observed in offspring of
MAA dams, repeated OVA challenges throughout gestation
resulted in altered weight and length developmental trajectories.
That is, offspring born to MAA-exposed dams were significantly
longer and heavier throughout juvenile development compared
with control offspring. Interestingly, a similar developmental
pattern was observed in offspring of mice exposed to human
IgG antibodies of mothers with a child diagnosed with autism.50
Prenatal exposure to environmental insults, including factors
contributing to allergies and asthma, are associated with child-
hood obesity,51 a condition that includes both systemic and
neuro-inflammation.52 Increased weight gain in offspring of MAA
dams may represent priming and reprogramming of metabolic
function through both immune and nervous system mechanisms,
as has been previously hypothesized.53,54 In fact, a recent
examination of metabolic changes in immune cells of mice born
to dams exposed to a viral mimic revealed persistent mitochon-
drial dysfunction in splenocytes.55,56 Interestingly, comorbid
metabolic dysregulation is highly prevalent in neurodevelopmen-
tal disorders including ASD,57 ADHD58 and schizophrenia,59
suggesting that environmental insults may impart pervasive
changes in homeostasis and regulation across organ systems.
The behavioral and physiological changes observed in offspring
of MAA-exposed dams during gestation strongly suggest that
maternal allergy/asthma alters basic developmental processes
that underlie fetal development. The serotonin pathway may link
increased immune activation during gestation with changes in
neural function in the offspring. It has previously been demon-
strated that peripheral immune responses can lead to changes in
serotonin levels in various brain regions.26 Numerous cytokines
have been shown to alter brain serotonin signaling through
disruption in transmitter synthesis and up/down regulation of
serotonin receptor expression.60–62 For example, interleukin-4
(IL-4), a cytokine highly expressed in allergy/asthma responses and
observed in BALF and sera of MAA dams, dose-dependently alters
serotonin uptake through modulation of SERT function.60 Conse-
quently in the current study, mice born to dams repeatedly
challenged with OVA during gestation had increased levels of
SERT protein in the cortex compared with offspring of dams
exposed to PBS during gestation. These increases in SERT
expression positively correlated with repetitive marble-burying
behavior. Interestingly, drugs that block SERT function, such as
selective serotonin reuptake inhibitors, suppress the marble-
burying behavior in mice, further supporting the link between
serotonin reuptake and repetitive behaviors.63 The SERT protein is
important for regulating synaptic serotonin levels and alterations
in serotonin function are implicated in a host of neuropsychiatric
diseases,64 including the repetitive stereotyped behaviors char-
acteristic of ASD.65 Disruptions in serotonin signaling, particularly
through gene-coding variants in SERT, are implicated in numerous
neurodevelopmental disorders.66–68 Increases in SERT levels in the
offspring of MAA dams may result in excessive uptake of serotonin
and a reduction in postsynaptic signaling. In mice, gain-of-
function coding variants for the human SERT gene (SLC6A4) results
in altered homeostasis of serotonin levels and behavioral
deficits.69 Moreover, in a rat model of maternal immune activation
fetal brains of dams exposed to poly(I:C) exhibited increased
serotonergic neurons and reductions in serotonin content.70
Considering the role of serotonin in behavior, the sensitivity of
the developing serotonin system to perturbations by immune
system signaling, and the links between SERT gene variants and
neurodevelopmental disorders, the serotonin system is a likely
target where genetic and environmental insults converge to
disrupt neurodevelopment.
For almost two decades, researchers have relied on a classic
experimental model of allergic asthma in which mice are
systemically sensitized to a foreign antigen (that is, OVA) to
induce the production of OVA-specific TH2 cells and OVA-specific
IgE antibodies.71 Subsequent exposures to aerosolized OVA results
in rapid mass infiltration of TH2 cells in the airways, increased
mucus production and development of airway hyper-
responsiveness. This model produces the hallmark immunological
responses analogous to those observed in humans including
elevated levels of the cytokine profile (for example, IL-4 and IL-5)
governing the initiation and progression of asthma.71,72 Tradition-
ally, the Balb/c mouse has been the most widely used model to
study allergic asthma as this strain has a prototypical TH2-skewed
phenotype.39,73 However, the use of this mouse strain in our
experimental model is confounded as Balb/c mice exhibit innate
deficits in social approach and increased anxiety,74 thus limiting
its use in the study of the behavioral consequences of MAA.
Conversely, although the highly social C57Bl/6 strain has
previously been used in the OVA-induced asthma paradigm, it
possesses a TH1 polarized phenotype resulting in an attenuated
allergic response when compared with the Balb/c mouse.41
Importantly, this predisposition does not prevent an allergic
phenotype from developing upon OVA sensitization and
subsequent OVA challenge but may be protective in mitigating
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its full behavioral effects. The genetic predisposition for TH1- or
TH2-specific polarization coupled with their associated behavioral
phenotypes provide additional insight into possible connections
between immune activation and behavioral and biological
responses in general and also specific to allergies and asthma.
That is, the low sociability inherent in the Balb/c strain may be, in
part, due to its underlying TH2-skewed immune profile. These
observations from our model and from the Balb/c strain
eloquently demonstrate the important contributions of both
genes and environment on neurodevelopment and highlight the
importance of strain selection when measuring the neuroimmu-
nological effects of discrete environmental insults.
To date, there are few epidemiological studies examining the
neurodevelopmental risk factors associated with maternal aller-
gies and asthma. A recent report exploring the maternal cytokine
profiles that may act as risk factors contributing to neurodevelop-
mental disorders identified an altered cytokine profile during the
second trimester in women who gave birth to a child later
diagnosed with ASD.6 This cytokine profile showed elevated IFN-γ,
IL-4 and IL-5 and was considered consistent with an allergic/
asthma clinical phenotype in humans,75–77 suggesting that
allergy/asthma exposure may be a factor that drives maternal
immune activation and increased risk for ASD. Moreover, Goines
et al.6 note that a different maternal cytokine profile during
pregnancy consisting of elevated IL-6 and IL-2 were associated
with having a child with other developmental disorders, but not
ASD. In our MAA model, we observed increased IL-4 and IL-5 in
both sera and BALF in mice challenged with OVA during
pregnancy. Similarly in humans, amniotic fluid taken from mothers
whose children were later diagnosed with ASD had elevated levels
of IL-4, whereas those with other developmental neuropsychiatric
disorders were noted to have increased levels of IL-6.78
Importantly, IL-6 is a pro-inflammatory cytokine released in
response to a range of immune-stimulating agents, including
both viral/bacterial infections and allergy/asthma, and is linked to
a host of neurological abnormalities and cognitive impairments
not specific to ASD.79–81 A large epidemiological study demon-
strated that mothers with new-onset allergies and asthma during
the time of pregnancy were at increased risk for having a child
with ASD.17 Interestingly, this is not consistent with another study
that looked at maternal allergies and asthma irrespective of
whether they were new onset or existing conditions and found no
association with ASD.18 The differences between studies may be
partly due to difference in ongoing treatment for asthma/allergies
and the suppression of immune activation by individuals with an
ongoing history of allergies/asthma. This variability in the clinical
population suggests that strategies may be present to mitigate
the neurodevelopmental consequences of maternal allergies/
asthma and imparts a need to explore how various treatments
commonly employed in allergy and asthma response may also
alter fetal development.
CONCLUSIONS
Allergy/asthma-induced activation of the maternal immune
system imparts behavioral and neurobiological alterations in
offspring that resemble features observed across neurodevelop-
mental disorders. These findings are concerning given the range
of stimuli associated with allergies and asthma. For example,
exposure to air pollutants, such as diesel fuel and other particulate
matter, can result in the development of asthma, and exposure to
pollutants is associated with an increased risk of having a child
with a neurodevelopmental disorder.82,83 Similarly, phthalates and
other plasticizers ubiquitous in our environment are known
neurotoxins associated with both increased risk of asthma and
neurodevelopmental disorders,84–87 highlighting the myriad
environmental triggers that may be contributing to the etiology
of these diseases. Together, the behavioral consequences of
maternal allergy/asthma along with the observed changes in brain
chemistry support the notion that the maternal immune system
has a crucial role in shaping fetal development and is an
important factor contributing to the etiology of neurodevelop-
mental disorders.
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